KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Shares Repurchased: 2021-2023

Historic Shares Repurchased for Moderna (MRNA) over the last 2 years, with Sep 2023 value amounting to -$1.0 million.

  • Moderna's Shares Repurchased fell 100.10% to -$1.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.6 billion, marking a year-over-year decrease of 58.91%. This contributed to the annual value of $1.2 billion for FY2023, which is 65.36% down from last year.
  • Latest data reveals that Moderna reported Shares Repurchased of -$1.0 million as of Q3 2023, which was down 100.16% from $628.0 million recorded in Q2 2023.
  • Over the past 5 years, Moderna's Shares Repurchased peaked at $1.3 billion during Q2 2022, and registered a low of -$1.0 million during Q3 2023.
  • In the last 3 years, Moderna's Shares Repurchased had a median value of $625.5 million in 2022 and averaged $667.4 million.
  • Data for Moderna's Shares Repurchased shows a maximum YoY plummeted of 100.10% (in 2023) over the last 5 years.
  • Quarterly analysis of 3 years shows Moderna's Shares Repurchased stood at $857.0 million in 2021, then crashed by 53.09% to $402.0 million in 2022, then crashed by 100.10% to -$1.0 million in 2023.
  • Its Shares Repurchased stands at -$1.0 million for Q3 2023, versus $628.0 million for Q2 2023 and $526.0 million for Q1 2023.